Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

What is Zacks Research's Estimate for Nutrien Q2 Earnings?

Nutrien logo with Basic Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Zacks Research raised its Q2 2026 EPS estimate for Nutrien to $2.47 from $2.38, and kept a Hold rating on the stock.
  • Other analysts have been mostly constructive, with several recent target-price increases; MarketBeat says Nutrien’s consensus rating is Moderate Buy with a $82.75 average price target.
  • Nutrien also beat its latest quarterly estimates, reporting $0.51 EPS on $6.05 billion in revenue, and it announced a quarterly dividend of $0.55 per share, or $2.20 annualized.
  • MarketBeat previews top five stocks to own in June.

Nutrien Ltd. (NYSE:NTR - Free Report) - Analysts at Zacks Research increased their Q2 2026 earnings per share estimates for shares of Nutrien in a report released on Tuesday, May 19th. Zacks Research analyst Team now anticipates that the company will earn $2.47 per share for the quarter, up from their previous estimate of $2.38. Zacks Research currently has a "Hold" rating on the stock. The consensus estimate for Nutrien's current full-year earnings is $5.42 per share. Zacks Research also issued estimates for Nutrien's Q3 2026 earnings at $0.91 EPS, Q4 2026 earnings at $0.91 EPS, FY2026 earnings at $4.63 EPS, Q1 2027 earnings at $0.61 EPS, Q2 2027 earnings at $1.24 EPS, Q3 2027 earnings at $0.84 EPS, Q4 2027 earnings at $0.97 EPS, FY2027 earnings at $3.66 EPS, Q1 2028 earnings at $0.76 EPS and FY2028 earnings at $4.09 EPS.

A number of other equities research analysts also recently weighed in on the stock. Scotiabank boosted their price objective on shares of Nutrien from $75.00 to $80.00 and gave the company a "sector perform" rating in a research report on Monday, May 11th. Oppenheimer raised their target price on shares of Nutrien from $80.00 to $82.00 and gave the stock an "outperform" rating in a report on Tuesday, May 12th. JPMorgan Chase & Co. boosted their price objective on Nutrien from $78.00 to $80.00 and gave the company an "overweight" rating in a research report on Monday, May 11th. BNP Paribas Exane downgraded Nutrien from an "outperform" rating to a "neutral" rating in a research note on Monday, February 23rd. Finally, Raymond James Financial raised Nutrien from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $74.00 to $90.00 in a research report on Tuesday, May 5th. Eleven research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Nutrien currently has a consensus rating of "Moderate Buy" and a consensus target price of $82.75.

View Our Latest Report on Nutrien

Nutrien Stock Up 0.2%

Shares of NYSE:NTR opened at $70.28 on Friday. The company's fifty day moving average is $74.17 and its two-hundred day moving average is $67.97. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.59 and a current ratio of 1.24. Nutrien has a 1-year low of $53.03 and a 1-year high of $85.36. The stock has a market capitalization of $33.79 billion, a price-to-earnings ratio of 14.31, a price-to-earnings-growth ratio of 0.65 and a beta of 0.64.

Nutrien (NYSE:NTR - Get Free Report) last released its quarterly earnings data on Wednesday, May 6th. The company reported $0.51 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.03. Nutrien had a net margin of 8.58% and a return on equity of 8.84%. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $5.30 billion. During the same quarter in the previous year, the company posted $0.11 earnings per share. The firm's revenue was up 18.5% on a year-over-year basis.

Nutrien Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.55 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 annualized dividend and a dividend yield of 3.1%. Nutrien's dividend payout ratio (DPR) is 44.81%.

Institutional Trading of Nutrien

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Montag A & Associates Inc. lifted its stake in Nutrien by 310.7% during the fourth quarter. Montag A & Associates Inc. now owns 423 shares of the company's stock valued at $26,000 after purchasing an additional 320 shares during the last quarter. Evolution Wealth Management Inc. bought a new position in shares of Nutrien in the first quarter valued at $32,000. Root Financial Partners LLC acquired a new stake in shares of Nutrien during the 3rd quarter valued at $37,000. Sfam LLC bought a new stake in shares of Nutrien during the 4th quarter worth $37,000. Finally, Eastern Bank boosted its stake in shares of Nutrien by 133.0% during the 4th quarter. Eastern Bank now owns 699 shares of the company's stock worth $43,000 after acquiring an additional 399 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors.

Key Stories Impacting Nutrien

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Zacks raised its FY2026 EPS estimate for Nutrien to $4.63 from $4.41, signaling improved expectations for the current year. Nutrien stock page
  • Positive Sentiment: The firm also lifted its Q2 2026 estimate to $2.47 from $2.38, Q3 2026 to $0.91 from $0.75, Q4 2026 to $0.91 from $0.81, and Q1 2028 to $0.76 from $0.64, which may support sentiment around near-term earnings strength. Nutrien stock page
  • Neutral Sentiment: Zacks maintained a Hold rating on Nutrien, suggesting analysts are not yet calling for a clear rerating higher. Nutrien stock page
  • Negative Sentiment: Longer-term profit expectations were trimmed, including FY2027 EPS to $3.66 from $4.29, FY2028 EPS to $4.09 from $4.59, Q1 2027 EPS to $0.61 from $0.68, Q2 2027 EPS to $1.24 from $1.87, and Q3 2027 EPS to $0.84 from $0.93, which could weigh on the stock. Nutrien stock page

Nutrien Company Profile

(Get Free Report)

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien's business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.

Further Reading

Earnings History and Estimates for Nutrien (NYSE:NTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Nutrien Right Now?

Before you consider Nutrien, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.

While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines